← All Sponsors
SPONSOR

ImStem Biotechnology

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Multiple Sclerosis
NCT04956744 Phase 1
Recruiting

A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis

Multiple Sclerosis
United States View Trial →